Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures.

Articular cartilage is rich in collagen type II fibres and proteoglycans and is characterized by low cell density. Chondrocytes have specific nutritional requirements and therefore cannot be expanded in vitro without the risk of generating fibroblastoid cells expressing type I collagen. Therefore, various growth conditions were tested for cartilage tissue engineering. Human platelets are a rich source of many growth factors including transforming growth factor-beta and platelet-derived growth factor. To investigate the effect of human platelet supernatant (hPS) on chondrocyte proliferation and differentiation, human articular biopsies obtained from three healthy donors. Chondrocytes were isolated and expanded separately in monolayer cultures and seeded in alginate beads in the presence and absence of hPS of 1% or 10% v/v concentration. Transcript levels of genes encoding chondrogenic factors were determined by quantitative reverse transcriptase-polymerase chain reaction. The deposition of types I and II collagen as well as proteoglycan was detected by indirect immunocytochemistry. Addition of hPS activated chondrocyte proliferation in monolayer cultures but induced a dedifferentiation of chondrocytes towards a fibroblast-like phenotype. The expression levels of mRNAs encoding type II collagen, aggrecan and bone morphogenetic protein-2 were reduced in all samples tested. Seeding chondrocytes in alginate beads in the presence of hPS generated a cell population capable of type II collagen expression, even though hPS induced considerable type I collagen expression as well. Differences (1% vs. 10% group, 1% vs. control, 10% vs. control) in the quantitative gene expression of types I and II collagen or of aggrecan were statistically significant (p<0.001). We conclude that addition of hPS may accelerate chondrocyte expansion but can lead to their dedifferentiation.

[1]  E. Thonar,et al.  Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. , 1996, Arthritis and rheumatism.

[2]  F. Luyten,et al.  Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. , 2001, Arthritis and rheumatism.

[3]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[4]  M. Brittberg,et al.  Two- to 9-Year Outcome After Autologous Chondrocyte Transplantation of the Knee , 2000, Clinical orthopaedics and related research.

[5]  J. Rhie,et al.  Platelet Supernatant Promotes Proliferation of Auricular Chondrocytes and Formation of Chondrocyte Mass , 2000, Annals of plastic surgery.

[6]  F. Luyten,et al.  Transforming growth factor-beta: Its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin , 1992, In Vitro Cellular & Developmental Biology - Animal.

[7]  Gary R. Grotendorst,et al.  Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. , 1985, The Journal of clinical investigation.

[8]  V. Lefebvre,et al.  Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α* , 2000, The Journal of Biological Chemistry.

[9]  F. Glorieux,et al.  Analysis of the type of collagen present in osteoarthritic human cartilage. , 1982, Clinical orthopaedics and related research.

[10]  C. Patrick,et al.  Prospectus of Tissue Engineering , 1998 .

[11]  Christoph Gaissmaier,et al.  Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. , 2004, Osteoarthritis and cartilage.

[12]  R. Ross,et al.  PLATELET-DERIVED GROWTH FACTOR , 1989, The Lancet.

[13]  M. Paulsson,et al.  Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes. , 2001, The Biochemical journal.

[14]  A. Ghosh,et al.  Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators , 2000, Oncogene.

[15]  E. Thonar,et al.  Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. , 1994, Journal of cell science.

[16]  J. Vacanti,et al.  Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. , 1994, International journal of oral and maxillofacial surgery.

[17]  N. Steimberg,et al.  Dedifferentiated chondrocytes cultured in alginate beads: Restoration of the differentiated phenotype and of the metabolic responses to Interleukin‐1β , 1998 .

[18]  H. Moses,et al.  Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Z. Deyl,et al.  Altered expression of collagen phenotype in osteoarthrosis. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[20]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[21]  R. Eavey,et al.  Influence of growth factors on tissue-engineered pediatric elastic cartilage. , 2000, Archives of otolaryngology--head & neck surgery.

[22]  R. Hewick,et al.  Recombinant human bone morphogenetic protein‐2 maintains the articular chondrocyte phenotype in long‐term culture , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  S. Gay,et al.  Immunohistological study on collagen in cartilage-bone metamorphosis and degenerative osteoarthrosis , 1976, Klinische Wochenschrift.

[24]  W. Richter,et al.  Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. , 2002, Biochemical and biophysical research communications.

[25]  P. Guerne,et al.  Growth factor responsiveness of human articular chondrocytes: Distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts , 1994, Journal of cellular physiology.

[26]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[27]  M. Heberer,et al.  Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro , 2001, Journal of cellular biochemistry.

[28]  R. Eavey,et al.  The effect of fibroblast growth factor and transforming growth factor-beta on porcine chondrocytes and tissue-engineered autologous elastic cartilage. , 2001, Tissue engineering.

[29]  G. Vunjak‐Novakovic,et al.  Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. , 1999, Experimental cell research.

[30]  M. Sporn,et al.  Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. , 1983, Science.

[31]  G. Vunjak‐Novakovic,et al.  Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF‐2 during 2D expansion and BMP‐2 during 3D cultivation , 2001, Journal of cellular biochemistry.

[32]  J. Buckwalter,et al.  Articular Cartilage and Osteoarthritis , 1954 .

[33]  C. Kaps,et al.  Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes , 2002, Medical and Biological Engineering and Computing.

[34]  P. Ruppel,et al.  Platelet-derived growth factor potentiates cellular responses of articular chondrocytes to interleukin-1. , 1991, Arthritis and rheumatism.

[35]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[36]  T. Anastassiades,et al.  Specificity and synergism of polypeptide growth factors in stimulating the synthesis of proteoglycans and a novel high molecular weight anionic glycoprotein by articular chondrocyte cultures. , 1998, The Journal of rheumatology.

[37]  E Wilmes,et al.  Effect of growth factors on cell proliferation by human nasal septal chondrocytes cultured in monolayer. , 1994, Acta oto-laryngologica.

[38]  K. Arden,et al.  Expression of the human chondrocyte phenotype in vitro , 1989, In Vitro Cellular & Developmental Biology.

[39]  D. Carnes,et al.  Pretreatment with platelet derived growth factor-BB modulates the ability of costochondral resting zone chondrocytes incorporated into PLA/PGA scaffolds to form new cartilage in vivo. , 2000, Biomaterials.

[40]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[41]  Antonios G. Mikos,et al.  Frontiers in tissue engineering , 1998 .

[42]  T. K. Hunt,et al.  Enhancement of wound healing by growth factors. , 1989, The New England journal of medicine.

[43]  F. Luyten,et al.  Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. , 1998, Arthritis and rheumatism.